Nattokinase for Arteries: Hype or Legit?

In this video, the presenter introduces nattokinase—a fermented soy‑derived enzyme—and examines whether it can truly reverse atherosclerosis. He cites a clinical study involving over 1,000 participants who took 10,800 units of nattokinase daily for one year, reporting a 21.7% reduction in carotid intima‑media thickness (CIMT) as measured by ultrasound. While acknowledging the study’s imperfections, he highlights the promising outcome. The speaker then outlines the proposed physiological actions of nattokinase: it functions as a natural ACE inhibitor lowering blood pressure, promotes vasodilation and salt‑fluid excretion, possesses antioxidant properties, and acts as an antithrombotic by interfering with the coagulation cascade and breaking down fibrin clots. He promises a more detailed deep‑dive for viewers seeking nuance.










